ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | John Kauwe |
| Institution: | Brigham Young University |
| Department: | Biology |
| Country: | |
| Proposed Analysis: | Aim 1: To measure mitochondrial genome copy number (mtGCN) in the ADNI samples. Aim 2: To examine the associations between mtGCN and Alzheimer’s disease in the ADNI samples. Aim 3: To examine the associations between select genetic variants in the mitochondrial and nuclear genome and mtGCN. ADNI phenotype data will be required to explore the mtGCN phenotype and its relationship to AD, imaging data and CSF biomarkers. |
| Additional Investigators | |
| Investigator's Name: | Richard Cawthon |
| Proposed Analysis: | Analysis of mtGCN phenotype for association with AD, imaging data and CSF biomarkers. |
| Investigator's Name: | Carlos Cruchaga |
| Proposed Analysis: | Assistance in Genetic Analysis |
| Investigator's Name: | Taylor Maxwell |
| Proposed Analysis: | Analysis of association between genetic markers and RBM phenotypes. |